natgillin/translations-raw huggingface dataset:
Available online: www.efsa.europa.eu.
Z Odločbo Komisije 2006/806/ES [3] je bilo potrjeno, da ortosulfamuron izpolnjuje pogoje iz člena 80(1)(a) Uredbe (ES) št. 1107/2009.
Commission Implementing Regulation (EU) 2017/841
Izvedbena uredba Komisije (EU) 2017/841
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, Ampelomyces quisqualis strain: aq 10, benalaxyl, bentazone, bifenazate, bromoxynil, carfentrazone ethyl, chlorpropham, cyazofamid, desmedipham, diquat, DPX KE 459 (flupyrsulfuron-methyl), etoxazole, famoxadone, fenamidone, flumioxazine, foramsulfuron, Gliocladium catenulatum strain: j1446, imazamox, imazosulfuron, isoxaflutole, laminarin, metalaxyl-m, methoxyfenozide, milbemectin, oxasulfuron, pendimethalin, phenmedipham, pymetrozine, s-metolachlor, and trifloxystrobin
o spremembi Izvedbene uredbe Komisije (EU) št. 540/2011 glede podaljšanja obdobij odobritve za aktivne snovi alfa-cipermetrin, Ampelomyces quisqualis sev: AQ 10, benalaksil, bentazon, bifenazat, bromoksinil, karfentrazon-etil, klorprofam, ciazofamid, desmedifam, dikvat, DPX KE 459 (flupirsulfuron-metil), etoksazol, famoksadon, fenamidon, flumioksazin, foramsulfuron, Gliocladium catenulatum sev: J1446, imazamoks, imazosulfuron, izoksaflutol, laminarin, metalaksil-M, metoksifenozid, milbemektin, oksasulfuron, pendimetalin, fenmedifam, pimetrozin, S-metolaklor in trifloksistrobin
Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC [1], and in particular the first paragraph of Article 17 thereof,
ob upoštevanju Uredbe (ES) št. 1107/2009 Evropskega parlamenta in Sveta z dne 21. oktobra 2009 o dajanju fitofarmacevtskih sredstev v promet in razveljavitvi direktiv Sveta 79/117/EGS in 91/414/EGS [1] ter zlasti prvega odstavka člena 17 Uredbe,
The approval periods of the active substances bentazone, diquat, DPX KE 459 (flupyrsulfuron-methyl), famoxadone, flumioxazine, metalaxyl-m and pymetrozine were last extended by Commission Implementing Regulation (EU) 2016/549 [3].
Obdobja odobritve za aktivne snovi bentazon, dikvat, DPX KE 459 (flupirsulfuron-metil), famoksadon, flumioksazin, metalaksil-M in pimetrozin so bila nazadnje podaljšana z Izvedbeno uredbo Komisije (EU) 2016/549 [3].
Applications for the renewal of the inclusion of those substances in Annex I to Council Directive 91/414/EEC [4] were submitted in accordance with Article 4 of Commission Regulation (EU) No 1141/2010 [5].
Odobritev navedenih snovi bo prenehala veljati 31. julija 2017.
The approval periods of the active substances carfentrazone ethyl, cyazofamid, fenamidone, foramsulfuron, imazamox, isoxaflutole, oxasulfuron, pendimethalin, and trifloxystrobin were last extended by Commission Implementing Regulation (EU) 2016/950 [6].The approval of those substances will expire on 31 July 2017.
Obdobja odobritve za aktivne snovi alfa-cipermetrin, Ampelomyces quisqualis sev: AQ 10, benalaksil, bifenazat, bromoksinil, klorprofam, desmedifam, etoksazol, Gliocladium catenulatum sev: J1446, imazosulfuron, laminarin, metoksifenozid, milbemektin, fenmedifam in S-metolaklor so bila podaljšana z Izvedbeno uredbo Komisije (EU) št. 1197/2012 [7].
The approval periods of the active substances alpha-cypermethrin, Ampelomyces quisqualis strain: aq 10, benalaxyl, bifenazate, bromoxynil, chlorpropham, desmedipham, etoxazole, Gliocladium catenulatum strain: j1446, imazosulfuron, laminarin, methoxyfenozide, milbemectin, phenmedipham, and s-metolachlor were extended by Commission Implementing Regulation (EU) No 1197/2012 [7].
Odobritev navedenih snovi bo prenehala veljati 31. julija 2017.
The approval of those substances will expire on 31 July 2017.
Zahtevki za obnovitev odobritve snovi, navedenih v uvodnih izjavah 3 in 4, so bili vloženi v skladu z Uredbo Komisije (EU) št. 844/2012 [8].
Applications for the renewal of the approval of substances listed in recitals 3 and 4 were submitted in accordance with Commission Implementing Regulation (EU) No 844/2012 [8].
Ker se je ocenjevanje snovi zavleklo iz razlogov, na katere vlagatelji ne morejo vplivati, obstaja možnost, da bodo odobritve navedenih aktivnih snovi potekle pred sprejetjem sklepa o njihovi obnovitvi.
Due to the fact that the assessment of the substances has been delayed for reasons beyond the control of the applicants, the approvals of those active substances are likely to expire before a decision has been taken on their renewal.
Zato je treba podaljšati njihova obdobja odobritve.
It is therefore necessary to extend their approval periods.
Glede na cilj prvega odstavka člena 17 Uredbe (ES) št. 1107/2009 v zvezi s primeri, v katerih Komisija sprejme uredbo, ki določa, da se odobritev aktivne snovi iz Priloge k tej uredbi ne obnovi, ker merila za odobritev niso izpolnjena, Komisija določi isti datum veljavnosti kot pred to uredbo ali datum začetka veljavnosti Uredbe, ki določa, da se odobritev aktivne snovi ne obnovi, odvisno od tega, kateri datum je poznejši.
In view of the aim of the first paragraph of Article 17 of Regulation (EC) No 1107/2009, as regards cases where the Commission will adopt a Regulation providing that the approval of an active substance referred to in the Annex to this Regulation is not renewed because the approval criteria are not satisfied, the Commission will set the expiry date at the same date as before this Regulation or at the date of the entry into force of the Regulation providing that the approval of the active substance is not renewed, whichever date is later.
V zvezi s primeri, v katerih Komisija sprejme uredbo o obnovitvi odobritve aktivne snovi iz Priloge k tej uredbi, bo Komisija poskusila določiti, kot je ustrezno v danih okoliščinah, najzgodnejši možni datum začetka uporabe.
As regards cases where the Commission will adopt a Regulation providing for the renewal of an active substance referred to in the Annex to this Regulation, the Commission will endeavour to set, as appropriate under the circumstances, the earliest possible application date.
Izvedbeno uredbo (EU) št. 540/2011 bi bilo zato treba ustrezno spremeniti.
Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly.
Ukrepi iz te uredbe so v skladu z mnenjem Stalnega odbora za rastline, živali, hrano in krmo –
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Člen 2
This Regulation shall be binding in its entirety and directly applicable in all Member States.
V Bruslju, 17. maja 2017
Done at Brussels, 17 May 2017.
Za Komisijo
Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 Implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the list of approved active substances (OJ L 153, 11.6.2011, p. 1).
Izvedbena uredba Komisije (EU) 2016/549 z dne 8. aprila 2016 o spremembi Izvedbene Uredbe (EU) št. 540/2011 glede podaljšanja obdobij odobritve za aktivne snovi bentazon, cihalofop butil, dikvat, famoksadon, flumioksazin, DPX KE 459 (flupirsulfuron-metil), metalaksil-M, pikolinafen, prosulfuron, pimetrozin, tiabendazol in tifensulfuron-metil (UL L 95, 9.4.2016, str. 4).
Commission Implementing Regulation (EU) 2016/549 of 8 April 2016 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances bentazone, cyhalofop butyl, diquat, famoxadone, flumioxazine, DPX KE 459 (flupyrsulfuron-methyl), metalaxyl-M, picolinafen, prosulfuron, pymetrozine, thiabendazole and thifensulfuron-methyl (OJ L 95, 9.4.2016, p. 4).
Direktiva Sveta 91/414/EGS z dne 15. julija 1991 o dajanju fitofarmacevtskih sredstev v promet (UL L 230, 19.8.1991, str.
1).
Uredba Komisije (EU) št. 1141/2010 z dne 7. decembra 2010 o postopku za podaljšanje vključitve druge skupine aktivnih snovi v Prilogo I k Direktivi Sveta 91/414/EGS in oblikovanju seznama navedenih snovi (UL L 322, 8.12.2010, str. 10).
Commission Regulation (EU) No 1141/2010 of 7 December 2010 laying down the procedure for the renewal of the inclusion of a second group of active substances in Annex I to Council Directive 91/414/EEC and establishing the list of those substances (OJ L 322, 8.12.2010, p. 10).
Izvedbena uredba Komisije (EU) 2016/950 z dne 15. junija 2016 o spremembi Izvedbene uredbe (EU) št. 540/2011 glede podaljšanja obdobja odobritve aktivnih snovi 2,4-DB, beta-ciflutrin, karfentrazon-etil, Coniothyrium minitans sev CON/M/91–08 (DSM 9660), ciazofamid, deltametrin, dimetenamid-p, etofumesat, fenamidon, flufenacet, flurtamon, foramsulfuron, fostiazat, imazamoks, jodosulfuron, iprodion, izoksaflutol, linuron, malein hidrazid, mezotrion, oksasulfuron, pendimetalin, pikoksistrobin, siltiofam in trifloksistrobin (UL L 159, 16.6.2016, str. 3).
Commission Implementing Regulation (EU) 2016/950 of 15 June 2016 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2,4-DB, beta-cyfluthrin, carfentrazone ethyl, Coniothyrium minitans Strain CON/M/91-08 (DSM 9660), cyazofamid, deltamethrin, dimethenamid-P, ethofumesate, fenamidone, flufenacet, flurtamone, foramsulfuron, fosthiazate, imazamox, iodosulfuron, iprodione, isoxaflutole, linuron, maleic hydrazide, mesotrione, oxasulfuron, pendimethalin, picoxystrobin, silthiofam and trifloxystrobin (OJ L 159, 16.6.2016, p. 3).
Izvedbena uredba Komisije (EU) št. 1197/2012 z dne 13. decembra 2012 o spremembi Izvedbene uredbe (EU) št. 540/2011 glede podaljšanja obdobij odobritve aktivnih snovi acetamiprid, alfa-cipermetrin, Ampelomyces quisqualis sev: AQ 10, benalaksil, bifenazat, bromoksinil, klorprofam, desmedifam, etoksazol, Gliocladium catenulatum sev: J1446, imazosulfuron, laminarin, mepanipirim, metoksifenozid, milbemektin, fenmedifam, Pseudomonas chlororaphis sev: MA 342, kvinoksifen, S-metolaklor, tepraloksidim, tiakloprid, tiram in ziram (UL L 342, 14.12.2012, str. 27).
Commission Implementing Regulation (EU) No 1197/2012 of 13 December 2012 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances acetamiprid, alpha-cypermethrin, Ampelomyces quisqualis Strain: AQ 10, benalaxyl, bifenazate, bromoxynil, chlorpropham, desmedipham, etoxazole, Gliocladium catenulatum Strain: J1446, imazosulfuron, laminarin, mepanipyrim, methoxyfenozide, milbemectin, phenmedipham, Pseudomonas chlororaphis Strain: MA 342, quinoxyfen, S-metolachlor, tepraloxydim, thiacloprid, thiram and ziram (OJ L 342, 14.12.2012, p. 27).
Izvedbena uredba Komisije (EU) št. 844/2012 z dne 18. septembra 2012 o opredelitvi določb, potrebnih za izvedbo postopka podaljšanja odobritve aktivnih snovi, kot je določeno z Uredbo (ES) št. 1107/2009 Evropskega parlamenta in Sveta o dajanju fitofarmacevtskih sredstev v promet (UL L 252, 19.9.2012, str. 26).
Commission Implementing Regulation (EU) No 844/2012 of 18 September 2012 setting out the provisions necessary for the implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (OJ L 252, 19.9.2012, p. 26).
PRILOGA
ANNEX
Del A Priloge k Izvedbeni uredbi (EU) št. 540/2011 se spremeni:
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
v šestem stolpcu vrstice 11 se za bentazon datum veljavnosti registracije nadomesti s „30. junij 2018“;
in the sixth column, expiration of approval, of row 11 Bentazone, the date is replaced by ‘30 June 2018’;
v šestem stolpcu vrstice 15 se za dikvat datum veljavnosti registracije nadomesti s „30. junij 2018“;
In the sixth column, expiration of approval, of row 15 Diquat, the date is replaced by ‘30 June 2018’;
v šestem stolpcu vrstice 19 se za DPX KE 459 (flupirsulfuron-metil) datum veljavnosti registracije nadomesti s „30. junij 2018“;
In the sixth column, expiration of approval, of row 19 DPX KE 459 (flupyrsulfuron-methyl), the date is replaced by ‘30 June 2018’;
v šestem stolpcu vrstice 23 se za pimetrozin datum veljavnosti registracije nadomesti s „30. junij 2018“;
In the sixth column, expiration of approval, of row 23 Pymetrozine, the date is replaced by ‘30 June 2018’;
v šestem stolpcu vrstice 35 se za famoksadon datum veljavnosti registracije nadomesti s „30. junij 2018“;
In the sixth column, expiration of approval, of row 35 Famoxadone, the date is replaced by ‘30 June 2018’;
v šestem stolpcu vrstice 37 se za metalaksil-M datum veljavnosti registracije nadomesti s „30. junij 2018“;
In the sixth column, expiration of approval, of row 37 Metalaxyl-M, the date is replaced by ‘30 June 2018’;
v šestem stolpcu vrstice 39 se za flumioksazin datum veljavnosti registracije nadomesti s „30. junij 2018“;
In the sixth column, expiration of approval, of row 39 Flumioxazine, the date is replaced by ‘30 June 2018’;
v šestem stolpcu vrstice 41 se za imazamoks datum veljavnosti registracije nadomesti z „31. julij 2018“;
In the sixth column, expiration of approval, of row 41 Imazamox, the date is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 42 se za oksasulfuron datum veljavnosti registracije nadomesti z „31. julij 2018“;
In the sixth column, expiration of approval, of row 42 Oxasulfuron, the date is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 44 se za foramsulfuron datum veljavnosti registracije nadomesti z „31. julij 2018“;
In the sixth column, expiration of approval, of row 44 Foramsulfuron, the date is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 46 se za ciazofamid datum veljavnosti registracije nadomesti z „31. julij 2018“;
In the sixth column, expiration of approval, of row 46 Cyazofamid, the date is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 53 se za pendimetalin datum veljavnosti registracije nadomesti z „31. julij 2018“;
In the sixth column, expiration of approval, of row 53 Pendimethalin, the date is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 59 se za trifloksistrobin datum veljavnosti registracije nadomesti z „31. julij 2018“;
In the sixth column, expiration of approval, of row 59 Trifloxystrobin, the date is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 60 se za karfentrazon-etil datum veljavnosti registracije nadomesti z „31. julij 2018“;
In the sixth column, expiration of approval, of row 60 Carfentrazone ethyl, the date is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 62 se za fenamidon datum veljavnosti registracije nadomesti z „31. julij 2018“;
In the sixth column, expiration of approval, of row 62 Fenamidone, the date is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 63 se za izoksaflutol datum veljavnosti registracije nadomesti z „31. julij 2018“;
In the sixth column, expiration of approval, of row 63 Isoxaflutole, the date is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 78 se za klorprofam datum veljavnosti registracije nadomesti z „31. julij 2018“;
In the sixth column, expiration of approval, of row 78 Chlorpropham, the date is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 83 se za alfa-cipermetrin datum veljavnosti registracije nadomesti z „31. julij 2018“;
In the sixth column, expiration of approval, of row 83 Alpha-cypermethrin, the date is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 84 se za benalaksil datum veljavnosti registracije nadomesti z „31. julij 2018“;
In the sixth column, expiration of approval, of row 84 Benalaxyl, the date is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 85 se za bromoksinil datum veljavnosti registracije nadomesti z „31. julij 2018“;
In the sixth column, expiration of approval, of row 85 Bromoxynil, the date is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 86 se za desmedifam datum veljavnosti registracije nadomesti z „31. julij 2018“;
In the sixth column, expiration of approval, of row 86 Desmedipham, the date is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 88 se za fenmedifam datum veljavnosti registracije nadomesti z „31. julij 2018“;
In the sixth column, expiration of approval, of row 88 Phenmedipham, the date is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 93 se za Ampelomyces quisqualis sev: AQ 10 datum veljavnosti registracije nadomesti z „31. julij 2018“;
In the sixth column, expiration of approval, of row 93 Ampelomyces quisqualis Strain: AQ 10, the date is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 95 se za laminarin datum veljavnosti registracije nadomesti z „31. julij 2018“;
In the sixth column, expiration of approval, of row 95 Laminarin, the date is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 96 se za metoksifenozid datum veljavnosti registracije nadomesti z „31. julij 2018“;
In the sixth column, expiration of approval, of row 96 Methoxyfenozide, the date is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 97 se za S-metolaklor datum veljavnosti registracije nadomesti z „31. julij 2018“;
In the sixth column, expiration of approval, of row 97 S-metolachlor, the date is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 98 se za Gliocladium catenulatum sev: J1446 datum veljavnosti registracije nadomesti z „31. julij 2018“;
In the sixth column, expiration of approval, of row 98 Gliocladium catenulatum Strain: J1446, the date is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 99 se za etoksazol datum veljavnosti registracije nadomesti z „31. julij 2018“;
In the sixth column, expiration of approval, of row 99 Etoxazole, the date is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 109 se za bifenazat datum veljavnosti registracije nadomesti z „31. julij 2018“;
In the sixth column, expiration of approval, of row 109 Bifenazate, the date is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 110 se za milbemektin datum veljavnosti registracije nadomesti z „31. julij 2018“;
In the sixth column, expiration of approval, of row 110 Milbemectin, the date is replaced by ‘31 July 2018’.
Odobritev navedenih snovi bo prenehala veljati 30. junija 2017.
Commission Implementing Regulation (EU) 2017/842
Izvedbena uredba Komisije (EU) 2017/842
renewing the approval of the low-risk active substance Coniothyrium minitans strain CON/M/91-08 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011
o obnovitvi odobritve aktivne snovi z majhnim tveganjem Coniothyrium minitans, sev CON/M/91-08, v skladu z Uredbo (ES) št. 1107/2009 Evropskega parlamenta in Sveta o dajanju fitofarmacevtskih sredstev v promet ter o spremembi Priloge k Izvedbeni uredbi Komisije (EU) št. 540/2011
Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC [1], and in particular Article 22(1) in conjunction with Article 20(1) thereof,
ob upoštevanju Uredbe (ES) št. 1107/2009 Evropskega parlamenta in Sveta z dne 21. oktobra 2009 o dajanju fitofarmacevtskih sredstev v promet in razveljavitvi direktiv Sveta 79/117/EGS in 91/414/EGS [1] ter zlasti člena 22(1) v povezavi s členom 20(1) Uredbe,
Commission Directive 2003/79/EC [2] included Coniothyrium minitans strain CON/M/91-08 as an active substance in Annex I to Council Directive 91/414/EEC [3].
Z Direktivo Komisije 2003/79/ES [2] je bil Coniothyrium minitans, sev CON/M/91-08, vključen v Prilogo I k Direktivi Sveta 91/414/EGS [3] kot aktivna snov.
The approval of the active substance Coniothyrium minitans strain CON/M/91-08, as set out in Part A of the Annex to Implementing Regulation (EU) No 540/2011, expires on 31 October 2017.
Odobritev aktivne snovi Coniothyrium minitans, sev CON/M/91-08, kot je določena v delu A Priloge k Izvedbeni uredbi (EU) št. 540/2011, preneha veljati 31. oktobra 2017.
An application for the renewal of the approval of Coniothyrium minitans strain CON/M/91-08 was submitted in accordance with Article 1 of Commission Implementing Regulation (EU) No 844/2012 [5] within the time period provided for in that Article.
Zahtevek za obnovitev odobritve Coniothyrium minitans, sev CON/M/91-08, je bil predložen v skladu s členom 1 Izvedbene uredbe Komisije (EU) št. 844/2012 [5] v roku, določenem v navedenem členu.
The rapporteur Member State prepared a renewal assessment report in consultation with the co-rapporteur Member State and submitted it to the European Food Safety Authority (‘the Authority’) and the Commission on 29 May 2015.
Država članica poročevalka je pripravila poročilo o oceni obnovitve v posvetovanju z državo članico soporočevalko ter ga 29. maja 2015 predložila Evropski agenciji za varnost hrane (v nadaljnjem besedilu: Agencija) in Komisiji.
On 8 June 2016 the Authority communicated to the Commission its conclusion [6] on whether Coniothyrium minitans strain CON/M/91-08 can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009.
Komisiji je 8. junija 2016 predložila svoj sklep [6] o tem, ali se za aktivno snov Coniothyrium minitans, sev CON/M/91-08, lahko pričakuje, da bo izpolnjevala merila za odobritev iz člena 4 Uredbe (ES) št. 1107/2009.
The Commission presented the draft renewal report for Coniothyrium minitans strain CON/M/91-08 to the Standing Committee on Plants, Animals, Food and Feed on 6 December 2016.
Komisija je osnutek poročila o obnovitvi za Coniothyrium minitans, sev CON/M/91-08, 6. decembra 2016 predložila Stalnemu odboru za rastline, živali, hrano in krmo.
The applicant was given the possibility to submit comments on the renewal report.
Vlagatelju je bilo omogočeno, da predloži pripombe na poročilo o obnovitvi.
It has been established with respect to one or more representative uses of at least one plant protection product containing Coniothyrium minitans strain CON/M/91-08 that the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009 are satisfied.
V zvezi z eno ali več reprezentativnimi uporabami vsaj enega fitofarmacevtskega sredstva, ki vsebuje Coniothyrium minitans, sev CON/M/91-08, je bilo ugotovljeno, da so merila za odobritev iz člena 4 Uredbe (ES) št. 1107/2009 izpolnjena.
It is therefore appropriate to renew the approval of Coniothyrium minitans strain CON/M/91-08.
Zato je primerno obnoviti odobritev Coniothyrium minitans. sev CON/M/91-08.
The risk assessment for the renewal of the approval of Coniothyrium minitans strain CON/M/91-08 is based on a limited number of representative uses, which however do not restrict the uses for which plant protection products containing Coniothyrium minitans strain CON/M/91-08 may be authorised.
Ocena tveganja za obnovitev odobritve Coniothyrium minitans, sev CON/M/91-08, temelji na omejenem številu reprezentativnih uporab, ki pa ne omejujejo uporab, za katere se lahko registrirajo fitofarmacevtska sredstva, ki vsebujejo Coniothyrium minitans, sev CON/M/91-08.
It is therefore appropriate not to maintain the restriction to use only as a fungicide.
Zato je primerno, da se omejitev na uporabo navedene snovi le kot fungicida ne ohrani.
The Commission further considers that Coniothyrium minitans strain CON/M/91-08 is a low-risk active substance pursuant to Article 22 of Regulation (EC) No 1107/2009.
Komisija je poleg tega menila, da je Coniothyrium minitans, sev CON/M/91-08, aktivna snov z majhnim tveganjem v skladu s členom 22 Uredbe (ES) št. 1107/2009.
Coniothyrium minitans strain CON/M/91-08 is not a substance of concern and fulfils the conditions set in point 5 of Annex II to Regulation (EC) No 1107/2009.
Coniothyrium minitans, sev CON/M/91-08, ni problematična snov in izpolnjuje pogoje iz točke 5 Priloge II k Uredbi (ES) št. 1107/2009.
Coniothyrium minitans strain CON/M/91-08 is a wild-type strain naturally occurring in the environment.
Coniothyrium minitans, sev CON/M/91-08, je sev divjega tipa, ki obstaja v naravni obliki v okolju.